Skip to main content
. 2021 Apr 1;98(2):E222–E234. doi: 10.1002/ccd.29674

TABLE 1.

Baseline, procedural, and in‐hospital management characteristics stratified by timing of insertion of Impella 2.5 and CP in relation to the interventional procedure in patients with cardiogenic shock

Overall (N = 191) Before (N = 77) During/after (N = 114) p‐value
Age 66 [55;73] 67 [58;74] 62 [54;73] .12
Male 73% (140) 73% (56) 74% (84) 1
Hypertension 54% (100) 56% (42) 53% (58) .75
Dyslipidemia 43% (79) 48% (36) 39% (43) .27
Diabetes mellitus 35% (65) 36% (27) 35% (65) .88
Chronic pulmonary disease 11%21 13%10 10%11 .64
Prior MI 36% (67) 44% (33) 31% (34) .08
Prior PCI 34% (63) 36% (27) 33% (36) .75
Prior CABG 5%10 8%6 4%4 .32
CKDa 25% (47) 27%20 25% (27) .86
AF 10%19 11%8 10%11 1
Prior TIA/stroke 5%10 7%5 5%5 .75
PAD 14% (26) 16%12 13%14 .64
Chronic HF 25% (47) 31%23 22%24 .22
LVEF, % 25 [20;30] 25 [20;30] 22 [15;32] .64
RV dysfunction 24% (42) 18%13 28% (29) .09
INTERMACS class 1 63% (116) 54% (39) 69% (77) .03
Out of hospital cardiac arrest 25% (46) 21%16 28% (30) .34
Etiology of cardiogenic shock
AMI 85% (163) 79% (61) 90% (102) .10
Acute myocarditis 3%5 5%4 1%1
Arrhythmias 4%8 4%3 4%5
Other 8%15 12%9 5%6
Laboratory values
Ph 7.4 [7.3;7.5] 7.4 [7.3;7.5] 7.4 [7.3;7.4] .33
HR (bpm) 100 [80;110] 100 [77;110] 98 [80;110] .86
MAP 63 [53;78] 65 [53;80] 60 [53;77] .56
Baseline lactate (mmol/l) 4.7 [2.6;7.5] 3 [2.2;6.4] 5 [3.1;7.5] .04
Baseline hemoglobin (g/dl) 12.3 [10.6;14.2] 12.2 [10.7;14.1] 12.4 [10.4;14.2] .98
Baseline creatinine (mg/dl) 1.2 [1;1.8] 1.3 [0.9;1.8] 1.3 [1;1.8] .91
Procedural characteristics
PCI performed 80% (147) 76% (55) 82% (92) .36
Number of diseased vessels 2 [1;3] 2.5 [1.3; 3] 2 [1;3] .09
Three vessels disease 42% (75) 50% (35) 37% (40) .09
BCIS myocardial jeopardy score 8 [6;12] 10 [6;12] 8 [6;12] .42
Left Main stenosis 36% (60) 41%25 34% (35) .40
LAD stenosis 80% (132) 84% (51) 78% (81) .42
CX stenosis 58% (95) 69% (42) 52% (53) .04
RCA stenosis 58% (96) 75% (46) 48% (50) <.01
By‐pass occlusion 1%2 2%1 1%1 1
Number of treated vessels 1.3 ± 0.9 1.6 ± 0.9 1.2 ± 0.7 .01
Three vessels treated 13%22 23%14 7%8 .01
Rotablator 7%11 5%3 7%8 .77
Resuscitation required during index procedure 21% (40) 17%13 24% (27) .23
Resuscitation required after index procedure 31% (58) 26%20 34% (38) .42
In‐hospital management
Impella removed immediately after PCI 12%21 23%16 5%5 <.01
Duration of support (hours) 53 [24;120] 48 [8;120] 72 [24;120] .06
Use of Impella 2.5 61% (117) 48% (37) 70% (80) <.01
Use of Impella CP 39% (74) 52% (40) 30% (34) <.01
Other cardiopulmonary support used
Inotropes 74% (130) 69% (50) 77% (80) .30
Mechanical ventilation 75% (139) 71% (53) 78% (86) .30
ECMO 29% (55) 22%17 33% (38) .10
IABP 36% (67) 23%17 45% (50) <.01

Note: Results reported as n (%) for categorical variables and median (interquartile range) or mean ± SD for continuous variables as appropriate.

Abbreviations: AF, atrial fibrillation; AMI, acute myocardial infarction; BCIS, British Cardiovascular Intervention Society; CABG, coronary artery by‐pass graft; CKD, chronic kidney disease; COPD, Chronic pulmonary disease; Cx, circumflex coronary artery; ECMO, ExtraCorporeal Membrane Oxygenation; HF, heart failure; HR, heart rate; IABP, intra‐aortic balloon pump; LAD, left descending artery; LVEF, left ventricular ejection fraction; MAP, mean arterial pressure; MI, myocardial infarction; PAD, peripheral artery disease; PCI, percutaneous coronary intervention; RCA, right coronary artery; RV, right ventricular; TIA, transient ischemic attack.

a

Defined as eGFR <60 ml/min/1.73 m2.